Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 858

1.

A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells.

Png KJ, Halberg N, Yoshida M, Tavazoie SF.

Nature. 2011 Dec 14;481(7380):190-4. doi: 10.1038/nature10661.

PMID:
22170610
[PubMed - indexed for MEDLINE]
2.

miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.

Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S, Westermann F, Speleman F, Vandesompele J, Weinberg RA.

Nat Cell Biol. 2010 Mar;12(3):247-56. doi: 10.1038/ncb2024. Epub 2010 Feb 21.

PMID:
20173740
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases.

van der Pluijm G, Sijmons B, Vloedgraven H, Deckers M, Papapoulos S, Löwik C.

J Bone Miner Res. 2001 Jun;16(6):1077-91.

PMID:
11393785
[PubMed - indexed for MEDLINE]
4.

Endogenous human microRNAs that suppress breast cancer metastasis.

Tavazoie SF, Alarcón C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL, Massagué J.

Nature. 2008 Jan 10;451(7175):147-52. doi: 10.1038/nature06487.

PMID:
18185580
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.

Ma L, Teruya-Feldstein J, Weinberg RA.

Nature. 2007 Oct 11;449(7163):682-8. Epub 2007 Sep 26. Erratum in: Nature. 2008 Sep 11;455(7210):256.

PMID:
17898713
[PubMed - indexed for MEDLINE]
6.

Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis.

Kosaka N, Iguchi H, Hagiwara K, Yoshioka Y, Takeshita F, Ochiya T.

J Biol Chem. 2013 Apr 12;288(15):10849-59. doi: 10.1074/jbc.M112.446831. Epub 2013 Feb 25.

PMID:
23439645
[PubMed - indexed for MEDLINE]
Free PMC Article
7.
8.

Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.

Patel JB, Appaiah HN, Burnett RM, Bhat-Nakshatri P, Wang G, Mehta R, Badve S, Thomson MJ, Hammond S, Steeg P, Liu Y, Nakshatri H.

Oncogene. 2011 Mar 17;30(11):1290-301. doi: 10.1038/onc.2010.510. Epub 2010 Nov 8.

PMID:
21057539
[PubMed - indexed for MEDLINE]
9.

MicroRNA-21 targets tumor suppressor genes in invasion and metastasis.

Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY.

Cell Res. 2008 Mar;18(3):350-9. doi: 10.1038/cr.2008.24.

PMID:
18270520
[PubMed - indexed for MEDLINE]
Free Article
10.

MicroRNA miR-98 inhibits tumor angiogenesis and invasion by targeting activin receptor-like kinase-4 and matrix metalloproteinase-11.

Siragam V, Rutnam ZJ, Yang W, Fang L, Luo L, Yang X, Li M, Deng Z, Qian J, Peng C, Yang BB.

Oncotarget. 2012 Nov;3(11):1370-85.

PMID:
23211491
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis.

Pencheva N, Tran H, Buss C, Huh D, Drobnjak M, Busam K, Tavazoie SF.

Cell. 2012 Nov 21;151(5):1068-82. doi: 10.1016/j.cell.2012.10.028. Epub 2012 Nov 8.

PMID:
23142051
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Integrin cytoplasmic domain-associated protein-1 attenuates sprouting angiogenesis.

Brütsch R, Liebler SS, Wüstehube J, Bartol A, Herberich SE, Adam MG, Telzerow A, Augustin HG, Fischer A.

Circ Res. 2010 Sep 3;107(5):592-601. doi: 10.1161/CIRCRESAHA.110.217257. Epub 2010 Jul 8.

PMID:
20616313
[PubMed - indexed for MEDLINE]
Free Article
13.

A dominant negative type I insulin-like growth factor receptor inhibits metastasis of human cancer cells.

Sachdev D, Hartell JS, Lee AV, Zhang X, Yee D.

J Biol Chem. 2004 Feb 6;279(6):5017-24. Epub 2003 Nov 13.

PMID:
14615489
[PubMed - indexed for MEDLINE]
Free Article
14.

Connexin-43 upregulation in micrometastases and tumor vasculature and its role in tumor cell attachment to pulmonary endothelium.

Elzarrad MK, Haroon A, Willecke K, Dobrowolski R, Gillespie MN, Al-Mehdi AB.

BMC Med. 2008 Jul 22;6:20. doi: 10.1186/1741-7015-6-20.

PMID:
18647409
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Inhibition of metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail Tien-Hsien Liquid.

Chia JS, Du JL, Hsu WB, Sun A, Chiang CP, Wang WB.

BMC Cancer. 2010 Apr 30;10:175. doi: 10.1186/1471-2407-10-175.

PMID:
20429953
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.

Amemiya Y, Yang W, Benatar T, Nofech-Mozes S, Yee A, Kahn H, Holloway C, Seth A.

Breast Cancer Res Treat. 2011 Apr;126(2):373-84. doi: 10.1007/s10549-010-0921-0. Epub 2010 May 13.

PMID:
20464481
[PubMed - indexed for MEDLINE]
17.

Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer.

Shimo T, Kubota S, Yoshioka N, Ibaragi S, Isowa S, Eguchi T, Sasaki A, Takigawa M.

J Bone Miner Res. 2006 Jul;21(7):1045-59.

PMID:
16813525
[PubMed - indexed for MEDLINE]
18.

Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis.

Darash-Yahana M, Pikarsky E, Abramovitch R, Zeira E, Pal B, Karplus R, Beider K, Avniel S, Kasem S, Galun E, Peled A.

FASEB J. 2004 Aug;18(11):1240-2. Epub 2004 Jun 4.

PMID:
15180966
[PubMed - indexed for MEDLINE]
Free Article
19.

Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines.

Jackson JG, Zhang X, Yoneda T, Yee D.

Oncogene. 2001 Nov 1;20(50):7318-25.

PMID:
11704861
[PubMed - indexed for MEDLINE]
Free Article
20.

Differential inhibition of tumor angiogenesis by tie2 and vascular endothelial growth factor receptor-2 dominant-negative receptor mutants.

Stratmann A, Acker T, Burger AM, Amann K, Risau W, Plate KH.

Int J Cancer. 2001 Feb 1;91(3):273-82.

PMID:
11169947
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk